Back to Search
GREGORY VIDETIC, MD
MD
Radiation Oncology Physician
NPI: 1114982196IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
35082421V(OH)
Education
OTHER
Class of 1986
Research & Publications (20)
Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analysis classification.
PMID 19327899·Int J Radiat Oncol Biol Phys·2009
8-other
Primary malignant mesothelioma of the abdominal wall: complete response with radiotherapy alone.
PMID 18198923·Technol Cancer Res Treat·2008
5-case
Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort.
PMID 18374513·Int J Radiat Oncol Biol Phys·2008
8-other
Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: small-cell lung cancer (SCLC).
PMID 18793952·Int J Radiat Oncol Biol Phys·2008
6-review
Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases.
PMID 17056192·Int J Radiat Oncol Biol Phys·2007
4-observational
Impaired diffusion capacity predicts for decreased treatment tolerance and survival in limited stage small cell lung cancer patients treated with concurrent chemoradiation.
PMID 14739036·Lung Cancer·2004
8-other
Shifting from hypofractionated to "conventionally" fractionated thoracic radiotherapy: a single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation.
PMID 14529775·Int J Radiat Oncol Biol Phys·2003
8-other
Elective nodal irradiation (ENI) in locally advanced non-small-cell lung cancer (NSCLC): evidence versus opinion?
PMID 19362253·Int J Radiat Oncol Biol Phys·2009
8-other
Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction.
PMID 19668013·J Thorac Oncol·2009
3-trial
A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience.
PMID 19633473·J Thorac Oncol·2009
4-observational
Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients.
PMID 19487961·J Thorac Oncol·2009
8-other
Choice of radiotherapy planning modality influences toxicity in the treatment of locally advanced esophageal cancer.
PMID 19407936·J Gastrointest Cancer·2008
8-other
Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: non-small-Cell lung cancer (NSCLC).
PMID 18793953·Int J Radiat Oncol Biol Phys·2008
8-other
A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneity.
PMID 17414467·Am J Clin Oncol·2007
3-trial
Five-year survivors of brain metastases: a single-institution report of 32 patients.
PMID 16904847·Int J Radiat Oncol Biol Phys·2006
8-other
Primary carcinoid tumors of the lung: a role for radiotherapy.
PMID 17153907·Oncology (Williston Park)·2006
6-review
Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
PMID 15542160·Radiother Oncol·2004
4-observational
Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival.
PMID 12697879·J Clin Oncol·2003
8-other
Primary chemoradiation as definitive treatment for unresectable cancer of the trachea.
PMID 12712222·Can Respir J·2003
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9500 EUCLID AVE
CLEVELAND, OH 44195 - Phone
- (800) 223-2273
Quick Facts
- NPI
- 1114982196
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile